“…The publication year of the eligible studies was between 1988 and 2020. Of thirty-four trials, seventeen trials were performed on healthy participants (33–37,39,42–45,47,50,51,53,56,57,59) , three trials on those with peripheral or coronary vascular disease (28,32,41) , seven in patients with dyslipidemia (31,40,46,48,49,52,58) , two in patients with type 2 diabetes (29,60) , and one in patients with metabolic syndrome (30) , rheumatoid arthritis (38) , non-communicable disease (54) , non-alcoholic fatty liver disease (55) , and polycystic ovary syndrome (61) . Six trials were conducted in populations with overweight/obesity (37,45,55–57,61) , nine in those with normal weight (34,36,39,43,44,52,53,58,59) and the rest in mixed populations (28–31,32,33,35,38,40–42,46–51,54,60) .…”